Open Call: MedTech Innovator Asia Pacific Accelerator Program

This program is designed to support innovators who are developing solutions that can advance healthcare delivery, improve patient outcomes, and address unmet medical needs in diverse health systems. By connecting startups with global industry stakeholders, the accelerator helps bridge the gap between innovation and adoption, guiding companies toward successful commercialization.

Selected participants will join the exclusive 2026 cohort and gain high-profile visibility among healthcare investors, strategic partners, and decision-makers. Companies will receive one-on-one mentorship from experienced industry leaders, innovators, and peers, helping them navigate regulatory considerations, reimbursement pathways, pricing strategies, clinical validation needs, and partnership development. The accelerator also provides a customized virtual curriculum tailored to help each participant accelerate market readiness and scale their innovation across the Asia-Pacific region and beyond.

As part of the program, startups will have the opportunity to showcase their solutions during major industry events and pitch to a wide network of clinical, investment, and commercialization partners. The accelerator culminates in competitive evaluation rounds, where participants can compete for up to USD 300,000 in cash and prizes. Beyond financial support, the program emphasizes long-term relationship building and strategic guidance to prepare companies for sustainable growth in global markets.

This opportunity is ideal for medtech startups and health innovation teams that are ready to scale and are seeking collaboration, visibility, and support to enter or expand within the Asia-Pacific healthcare ecosystem. Companies should have a strong value proposition and be prepared to engage actively with mentors, refine their commercialization strategy, and work toward measurable milestones throughout the program.

For more information, visit MedTech Innovator.